Search or

𝛼SK

ENTITY

Hutchmed China Ltd (13 HK)

202

Analysis

Industrials • Hong Kong

HUTCHMED (China) Limited develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment. HUTCHMED (China) markets its products worldwide.

more

Refresh

Exchange Announcement • 17 Dec 2025 08:01

Voluntary Announcement - Hutchmed Initiates Global Clinical Development Of Attc Candidate Hmpl-A251 In Patients With Solid Tumors

Exchange Announcement • 08 Dec 2025 08:01

Voluntary Announcement - Hutchmed Announces Expanded Coverage On National Reimbursement Drug List And Inclusion In The First Commercial Insurance Drug List In China

Exchange Announcement • 28 Nov 2025 16:32

Total Voting Rights

Exchange Announcement • 27 Nov 2025 08:00

Voluntary Announcement - Hutchmed Highlights Clinical Data To Be Presented At The 2025 Esmo Asia Congress And The 2025 Ash Annual Meeting

Exchange Announcement • 05 Nov 2025 08:02

Voluntary Announcement - Hutchmed Announces Enrollment Completed Of Saffron Global Phase Iii Trial Of Orpathys And Tagrisso Combination For Certain Lung Cancer Patients With Met Overexpression And/Or Amplification After Progression On Tagrisso

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.60.3

x